[ad_1]
Report comes after Britain approved Oxford-AstraZeneca COVID-19 vaccine
About two million doses of the COVID-19 vaccine developed by the University of Oxford and AstraZeneca are expected to be delivered each week by mid-January in the UK, the Times reported.
AstraZeneca plans to deliver two million doses of the vaccine in total by next week, the newspaper reported, citing an anonymous member of the Oxford-AstraZeneca team. “The plan then is to build it fairly quickly – by the third week of January we should reach two million a week,” the report adds.
The company was not immediately available to respond to a request for comment from Reuters.
The report comes after Britain approved the Oxford-AstraZeneca COVID-19 vaccine on Wednesday, in hopes that swift action will help stem a record rise in infections caused by a highly contagious form of the virus.
Prime Minister Boris Johnson has ordered 100 million doses for the country as part of a deal with the company. The company had announced plans to deliver millions of doses in the first quarter, adding that the first vaccinations are expected to begin this year.
Britain, which has recorded more than 50,000 new daily cases of COVID-19 in the past four days, is facing rapid spread of a much more infectious variant of the coronavirus. The UK recorded 53,285 new COVID-19 cases and 613 deaths on Friday.
(Except for the title, this story was not edited by NDTV staff and is posted from a syndicated feed.)
[ad_2]
Source link